John L. Higgins
Director at Ligand Pharmaceuticals; Director at OmniAb; Director at Bio-Techne. Based in Minneapolis, Minnesota.
- Rank
- 1162nd of 14,644
- Companies held
- 3
- Largest holding
- LGND, 85.3% of total
- Latest SEC filing
- Oct 29, 2026
What the $141M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Ligand Pharmaceuticals LGND Common Stock | Directly | 417,695 | $286.94 | $120M | 85.3% | Form 4, Dec 28, 2022 |
| OmniAb OABI Common Stock | Directly | 2,962,320 | $5.03 | $14.9M | 10.6% | Form 4, Jun 17, 2026 |
| Bio-Techne TECH Common Stock | Directly | 80,004 | $72.70 | $5.8M | 4.1% | Form 4, Oct 29, 2026 |
Share counts are the amounts John L. Higgins reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 1159 | John Kristofer Galashan Director, Life Time Group Holdings. Los Angeles, CA | $141M |
| 1160 | Travis Murdoch CEO and President, Braveheart Bio. San Francisco, CA | $141M |
| 1161 | David R. Pelizzon Director, OrthoPediatrics. Granby, CT | $141M |
| 1162 | John L. Higgins Director, Ligand Pharmaceuticals. Minneapolis, MN | $141M |
| 1163 | Ramin Kamfar Director, Bluerock Private Real Estate Fund. New York, NY | $140M |
| 1164 | Kenneth S. Courtis Director, Alpha Metallurgical Resources. Bristol, TN | $140M |
| 1165 | David V. Auld Executive Chairman, D.R. Horton. Arlington, TX | $140M |
Other Ligand Pharmaceuticals insiders
All LGND insiders- Matthew W. Foehr$74.6MInsider. #1498 overall
- Todd C. Davis$57.2MChief Executive Officer. #1695 overall
- Jason Aryeh$31.7MDirector. #3493 overall
- Matthew E. Korenberg$14.6MPresident & COO. #6393 overall
- Sunil Patel$13.3MInsider. #6658 overall
- John W. Kozarich$12.1MDirector. #7621 overall
Questions
How much stock does John L. Higgins own?
John L. Higgins holds $140,570,164 in listed stock based on SEC filings and current prices, mostly Ligand Pharmaceuticals (LGND). That ranks 1162nd on the Stock Rich List.
Is this John L. Higgins's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did John L. Higgins last buy or sell stock?
The most recent open-market trade on file is a purchase of 41,038 OABI shares on Nov 7, 2025 at $1.38.